Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

  • STATUS
    Recruiting
  • End date
    Oct 30, 2022
  • participants needed
    3000
  • sponsor
    Duke University
Updated on 8 October 2020
Investigator
Tracy Hofmann
Primary Contact
MedStar Health Research Institute, Inc. (1.7 mi away) Contact
angiography
stemi
coronary artery bypass graft
acute myocardial infarction

Summary

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Details
Clinical Study IdentifierNCT04076813
SponsorDuke University
Last Modified on8 October 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Myocardial Ischemia or Ischemic Heart Disease or Cardiac Ischemia or Myocardial Infarction or Heart Attack (Myocardial Infarction)?
For the first 200 patients in the registry, consecutive patients are entered
in the registry if they are 18 years of age, underwent coronary angiography
for a STEMI or NSTEMI, and received cangrelor at any time during the
hospitalization or an oral P2Y12 inhibitor during his/her first 48 hours of
the hospitalization for MI

Exclusion Criteria

Subsequent patients are eligible to be entered in the registry if they are 18
years of age and underwent coronary angiography for a STEMI or NSTEMI and meet
at least 1 of the following criteria
The patient was hospitalized for STEMI and met one of the following inclusion
criteria
The patient received cangrelor at any time during his/her hospitalization for MI
The patient received an oral P2Y12 inhibitor during his/her first 48 hours of hospitalization AND either of the following
The patient received a P2Y12 inhibitor and an opiate/opioid within 24 hours prior to or during primary PCI for STEMI presentation
The patient underwent coronary angiography followed by CABG during the index MI admission and received any P2Y12 inhibitor within 7 days prior to CABG
The patient was hospitalized for NSTEMI and met one of the following inclusion
criteria
The patient received cangrelor during his/her hospitalization for MI
The patient received an oral P2Y12 inhibitor during his/her first 48 hours of hospitalization
The patient underwent coronary angiography followed by CABG during the index MI admission and received any P2Y12 inhibitor within 7 days prior to CABG
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet